News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,101 Results
Type
Article (2573)
Company Profile (45)
Press Release (37482)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14192)
Career Advice (78)
Deals (2107)
Drug Delivery (9)
Drug Development (4143)
Employer Resources (10)
FDA (443)
Job Trends (782)
News (20271)
Policy (1057)
Tag
Academia (144)
Allergies (7)
Alliances (3493)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (32)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (44)
Cancer (328)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3437)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (113)
Cystic fibrosis (7)
Data (418)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (491)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (37)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4500)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6401)
Executive appointments (135)
FDA (588)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (168)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (708)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1002)
IRA (7)
Job creations (293)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (314)
Medtech (315)
Mergers & acquisitions (1222)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (353)
Non-profit (155)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (12)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5878)
Pharmaceutical (5)
Phase 1 (1474)
Phase 2 (1702)
Phase 3 (915)
Pipeline (390)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (425)
Recruiting (5)
Regulatory (916)
Reports (7)
Research institute (149)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (46)
Series B (20)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (497)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (39)
Last 30 days (137)
Last 365 days (2414)
2026 (211)
2025 (2444)
2024 (2617)
2023 (2858)
2022 (3750)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1795)
2016 (1624)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1947)
Australia (307)
California (1607)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4019)
Florida (64)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (48)
Massachusetts (568)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (81)
North Carolina (131)
Northern California (781)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (111)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (658)
Tennessee (4)
Texas (152)
United States (3211)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (95)
West Virginia (1)
Wisconsin (13)
40,101 Results for "renovaro biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Peer-Reviewed Study Validates Renovaro’s Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy
July 18, 2025
·
3 min read
Biotech Beach
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
Renovaro Biosciences Inc. announced today the results of the Company’s Special Meeting of Shareholders held at 12:00 pm ET on January 25, 2024.
January 25, 2024
·
1 min read
Biotech Beach
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
Renovaro Inc. announced that it completed its acquisition of GEDi Cube Intl Ltd. Renovaro, which means renew, combines the power of the AI Health Tech platform of GEDiCube with the advanced cell and gene-therapy Biotech platform of Renovaro Biosciences to accelerate precision, personalized medicine, and a new era in healthcare innovation.
February 13, 2024
·
3 min read
Press Releases
Court Denies Renovaro Motion for an Expedited Trial in July
May 27, 2025
·
2 min read
Press Releases
Renovaro Provides Update to Definitive Agreement with Predictive Oncology
April 7, 2025
·
2 min read
Business
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
Renovaro Biosciences Inc. is pleased to announce the appointment of Leni Boeren and Ruud Hendriks as Independent Directors.
October 10, 2023
·
9 min read
Press Releases
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
April 10, 2025
·
6 min read
Press Releases
Renovaro Announces $15 million in Equity Committed
February 27, 2025
·
2 min read
Business
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
Renovaro Biosciences Inc., a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram Miller will join its Board of Directors.
October 11, 2023
·
8 min read
Business
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
Renovaro BioSciences congratulates GEDi Cube on its appointment of Dr. Lester Russell as Chief Medical Officer.
August 21, 2023
·
2 min read
1 of 4,011
Next
